Metabolic Changes of Brain Developmental Venous Anomalies on 18F-FDG-PET

Acad Radiol. 2019 Apr;26(4):443-449. doi: 10.1016/j.acra.2018.05.021. Epub 2018 Jun 28.

Abstract

Rationale and objectives: To determine the metabolic effects of developmental venous anomalies (DVAs) and to correlate those effects with conventional magnetic resonance imaging (MRI) findings.

Materials and methods: We conducted a retrospective review of MRI and brain 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) examinations in subjects with DVAs. Conventional MRI was used to determine DVA number, location, size, and associated parenchymal findings such as atrophy, hemorrhage, cavernoma, capillary telangiectasia, cortical dysplasia/polymicrogyria, and white matter signal abnormality. Qualitative and quantitative measures of relative metabolism in the drainage territory of the DVA were measured on 18F-FDG-PET.

Results: Fifty-four subjects with 57 DVAs were included in the analysis. 38% were associated with qualitative and quantitative metabolic abnormalities on 18F-FDG-PET, with decreased metabolism in the parenchyma surrounding all but one of these DVAs. DVAs draining gray matter were significantly more likely to be hypometabolic than those draining only white matter, suggesting that the metabolic effects of DVAs may be underestimated on 18F-FDG-PET.

Conclusion: Altered metabolism is seen in the drainage territory of a significant proportion of DVAs, suggesting that these anomalies are vascular lesions with abnormal physiologic features.

Keywords: (18)F-FDG-PET; brain; developmental venous anomalies.

MeSH terms

  • Adult
  • Brain* / diagnostic imaging
  • Brain* / metabolism
  • Brain* / pathology
  • Central Nervous System Vascular Malformations* / complications
  • Central Nervous System Vascular Malformations* / diagnostic imaging
  • Female
  • Fluorodeoxyglucose F18 / pharmacology*
  • Humans
  • Magnetic Resonance Imaging / methods*
  • Male
  • Middle Aged
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals / pharmacology
  • Retrospective Studies

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18